本文選題：人血白蛋白 + 臨床使用��； 參考：《實(shí)用藥物與臨床》2016年02期

【摘要】：目的了解我院人血白蛋白臨床使用情況,評價(jià)其用藥規(guī)范性。方法利用醫(yī)院電子病歷系統(tǒng),回顧性抽查我院2013年1月至2014年12月使用人血白蛋白的1 009例住院患者,收集相關(guān)臨床信息并統(tǒng)計(jì)。結(jié)果應(yīng)用人血白蛋白的患者以中老年為主;用藥原因以低蛋白血癥、營養(yǎng)支持為主;用藥前有28.15%的患者未檢測血清白蛋白濃度;對比美國UHC指南、臺(tái)灣人血白蛋白使用規(guī)定及中國人血白蛋白使用說明書,適應(yīng)證符合率分別為15.36%、24.08%、63.83%。結(jié)論我院人血白蛋白使用廣泛,但規(guī)范性較低,應(yīng)加強(qiáng)管理。
[Abstract]:Objective to investigate the clinical use of human serum albumin (HSA) in our hospital and evaluate its drug use standard. Methods A retrospective study of 1 009 inpatients with human serum albumin (HSA) from January 2013 to December 2014 was carried out with the hospital electronic medical record system. The clinical information was collected and counted. Results the main reasons for the use of human serum albumin were middle and old age, hypoproteinemia and nutritional support. 28.15% of the patients had not detected the serum albumin concentration before the treatment. The results were compared with the UHC guidelines in the United States. The indications of the regulations for the use of albumin in Taiwan and the instructions for the use of serum albumin in Chinese were 15.36% 24.08% and 63.83% respectively. Conclusion Human serum albumin is widely used in our hospital, but its standard is low, so management should be strengthened.
【作者單位】： 浙江省臺(tái)州學(xué)院醫(yī)學(xué)院附屬市立醫(yī)院;溫州醫(yī)科大學(xué)藥學(xué)院;
【基金】：浙江省藥學(xué)會(huì)醫(yī)院藥學(xué)專項(xiàng)科研基金(2012ZYY-35)
【分類號(hào)】：R95
，

本文編號(hào)：1804403